Supplemental material from Use of Liquid Biopsies in Clinical Oncology: Pilot Experience in 168 Patients
Year: 2023
Type: supplementary-materials
Abstract: Supplemental Table 1. Guardant360 54 gene cell-free DNA NGS panel. Complete exon coverage for genes in bold. Unbolded genes had critical exon coverage. Supplemental Table 2. Frequency of patients with metastatic/recurrent/advanced unresectable disease Supplemental Table 3. List of the 12 evaluable patients treated with a matched therapy targeting {greater than or equal to} 1 alteration detected by the ctDNA test. Supplemental Figure 1. Diagram of the population analyzed for treatment outcome
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: gold
OpenAlex ID: W4361923641